BoneView
Gleamer • Radiology • 03/01/2022
Device Purpose
BoneView is a software tool that utilizes supervised deep learning algorithms to analyze adult radiographs, functioning as a concurrent reading aid for clinicians to improve the detection of fractures across numerous anatomical regions. It processes DICOM images to identify and highlight potential fractures with distinct visual cues based on algorithmic confidence, aiming to enhance diagnostic sensitivity and specificity.
Summary
BoneView is a radiological computer-assisted detection software designed to aid clinicians in identifying fractures in adult patients using 2D X-ray images. It employs supervised deep learning algorithms to analyze radiographs across a wide range of anatomical areas, including extremities, pelvis, ribs, and spine. The software integrates with existing radiological infrastructure, such as PACS or X-ray systems, either through on-premise or cloud deployment. It processes DICOM images automatically, identifying potential regions of interest without altering the original radiographs, and generates result files including a summary table and annotated images for concurrent review. The system provides four levels of results, visually indicated by bounding boxes: solid lines for definite fractures (high-specificity) and dotted lines for suspicious or subtle fractures (high-sensitivity), alongside "NO FRACT" or "NOT AVAILABLE" classifications. Standalone bench testing on 8,918 radiographs demonstrated high global sensitivity (0.928 at high-sensitivity point) and specificity (0.932 at high-specificity point). A multi-reader, multi-case clinical study involving 24 readers and 480 cases showed that using BoneView as an aid significantly improved reader diagnostic accuracy, increasing sensitivity by 10.4% (from 0.648 to 0.752) and specificity by 5% (from 0.906 to 0.956) compared to unaided readings.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does BoneView's performance vary across different X-ray system manufacturers and image acquisition parameters not explicitly detailed in the bench testing?; What is the performance impact on fracture detection for patients with comorbidities or pre-existing bone conditions (e.g., osteoporosis, previous healed fractures) within the validated anatomical regions?; Could the 'DOUBT FRACT' (high-sensitivity) and 'FRACT' (high-specificity) thresholds be adjusted by users, and what is the impact of such adjustments on diagnostic accuracy in specific clinical settings?; What is the average processing time per study, and how might this vary with different deployment models (cloud vs. on-premise) and image set sizes?; How does the software handle images with significant artifacts or suboptimal quality, and what is the false positive/negative rate in such scenarios?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, SaaSBOM, OBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly